心力衰竭大鼠β3-肾上腺素能受体兴奋对室颤阈值和心室有效不应期的影响

目的: 观察实验性心力衰竭大鼠左心室β₃-肾上腺素能受体(AR)表达水平的变化及β₃-AR激动时对心脏室颤阈值（VFT）和心室有效不应期（ERP）的影响。方法: 雄性成年Wistar大鼠16只，随机分为心力衰竭组（n=8）及对照组（n=8）。结扎大鼠冠状动脉前降支致心肌梗死建立心力衰竭模型；使用RT-PCR法检测左心室β₃-AR mRNA的表达；观察使用β₃-AR激动剂BRL37344对VFT、ERP和LVESP、+dp/dtmax、-dp/dtmax的影响。结果： ①与对照组相比，心力衰竭大鼠左心室β₃-AR mRNA表达量(β₃/β-actin的比值) 增加（0.011 vs 0.028, P<0.05），所占比例(β₃/β₁+β₂+β₃) 增加（1.2% vs 5.4%, P<0.05）；②心力衰竭大鼠VERP较正常对照组VERP明显延长(70.5 ms±5.5 ms vs 59.5 ms±6.4 ms，P<0.05)；静注BRL37344后，心力衰竭大鼠VERP稍延长，但对比用药前VERP无显著差异(73.0 ms±4.8 ms vs 70.5 ms±5.5 ms，P>0.05)；③心力衰竭大鼠VFT较正常对照组VFT显著降低(10.9 mV±0.8 mV vs 30.5 mV±1.3 mV，P<0.05)；静注BRL37344后，心力衰竭大鼠VFT相比用药前亦显著降低(7.1 mV±0.6 mV vs 10.9 mV±0.8 mV，P<0.05)； BRL37344降低VFT的作用与BRL37344对LVESP、+dp/dtmax、-dp/dtmax及β₃-AR mRNA表达量的改变密切相关，相关系数分别为0.788、0.708、0.759、0.787(P<0.05)。结论： 心力衰竭大鼠左心室β₃-AR mRNA表达明显增高，β₃-AR激动时不影响衰竭大鼠心室ERP，但明显降低衰竭大鼠心脏VFT，其降低VFT作用与β₃-AR的负性肌力作用及β3-AR mRNA表达量的改变密切相关。

Effect of β3 -adrenoceptor activation on ventricle fibrillation threshold and effective refractory period in rats with heart failure

AIM: To observe the effect of β₃-adrenoceptor (AR) on ventricle fibrillation threshold (VFT) and effective refractory period (ERP) in rats with heart failure.METHODS: Rats were randomized into control group and heart failure group. The expression of β₃- AR mRNA was detected with RT-PCR. The VFT, ERP, left ventricle end-systolic pressure(LVESP)，left ventricle end-diastolic pressure(LVEDP), +dp/dtmax and -dp/dtmax were measured at the same time with administration of BRL37344 (β₃-AR agonist).RESULTS: ① Both the expression of β₃-AR mRNA and the proportion (β₃/β₁+β₂+β₃) were increased in failure rats comparied with those in control rats (0.028 vs 0.011 and 5.4% vs 1.2%, P<0.05). ② ERP was longer in rats with heart failure than that in control group (70.5 ms±5.5 ms vs 59.5 ms±6.4 ms, P<0.05). No difference in ERP in rats with heart failure was observed before and after administration of BRL37344 (73.0 ms±4.8 ms vs 70.5 ms±5.5 ms, P>0.05). ③ VFT was lower in rats with heart failure than that in control group (10.9 mV±0.8 mV vs 30.5 mV±1.3 mV, P<0.05) and decreased obviously in rats with heart failure after administration of BRL37344 (7.1 mV±0.6 mV vs 10.9 mV±0.8 mV, P<0.05). The decrease in VFT correlated with the effect of LVESP, +dp/dtmax, -dp/dtmax with BRL37344 and the expression of β₃-AR mRNA (correlation coefficient: 0.788, 0.708, 0.759, 0.787; P<0.05). CONCLUSION: The expression of β₃-AR mRNA in left ventricle is obviously increased in rats with heart failure. The activation of β₃-AR has no effect on ERP but can decrease VFT which correlates with the effect of β₃-AR on LVESP, +dp/dtmax, -dp/dtmax and the expression of β₃-AR mRNA.